Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
about
The promise of neuroprotective agents in Parkinson's diseaseThe gut hormones in appetite regulationExendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's diseasePeripheral glia have a pivotal role in the initial response to axon degeneration of peripheral sensory neurons in zebrafishRole of anti-diabetic drugs as therapeutic agents in Alzheimer's diseaseAlzheimer's disease and type 2 diabetes via chronic inflammatory mechanismsExendin-4 ameliorates motor neuron degeneration in cellular and animal models of amyotrophic lateral sclerosisA novel glucagon-related peptide (GCRP) and its receptor GCRPR account for coevolution of their family members in vertebratesTherapeutic Effect of Berberine on Huntington's Disease Transgenic Mouse ModelExenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in RatsA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseThe entero-insular axis: implications for human metabolism.Diabetes resolution and hyperinsulinaemia after metabolic Roux-en-Y gastric bypass.Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in miceGlucose-dependent insulinotropic polypeptide and glucagon-like peptide-1: Incretin actions beyond the pancreas.Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.Exendin-4 attenuates blast traumatic brain injury induced cognitive impairments, losses of synaptophysin and in vitro TBI-induced hippocampal cellular degenerationThe evolving place of incretin-based therapies in type 2 diabetesEnhancing the GLP-1 receptor signaling pathway leads to proliferation and neuroprotection in human neuroblastoma cells.GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.Glucagon-like peptides 1 and 2 and vasoactive intestinal peptide are neuroprotective on cultured and mast cell co-cultured rat myenteric neuronsGlutamate carboxypeptidase II inhibition behaviorally and physiologically improves pyridoxine-induced neuropathy in rats.Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryVitamin B6: a long known compound of surprising complexity.Exendin-4 ameliorates traumatic brain injury-induced cognitive impairment in rats.Beneficial effects of exendin-4 on experimental polyneuropathy in diabetic mice.GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic miceNeuroprotective effect of the glucagon-like peptide-1 receptor agonist, synthetic exendin-4, in streptozotocin-induced diabetic ratsPhysiology of incretins in health and disease.Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disordersLiraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction.Blast traumatic brain injury-induced cognitive deficits are attenuated by preinjury or postinjury treatment with the glucagon-like peptide-1 receptor agonist, exendin-4.Protection of trigonelline on experimental diabetic peripheral neuropathy.GLP-1 secretion by microglial cells and decreased CNS expression in obesity.Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals.GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism.Therapeutic effect of berberine on TDP-43-related pathogenesis in FTLD and ALS.Glucagon-like peptide 1 receptor stimulation as a means of neuroprotection.Incretin-based therapies.
P2860
Q21129436-0ABEEA77-0913-4D79-9A8B-D2F34F2416F3Q21296779-2F29F1E5-E5B8-4F54-B953-20B61CEAF484Q24647189-4639B800-C1F1-472D-AE78-6659BA8D6D17Q27317497-EB0525DA-D8FC-4987-AFCD-10CA964DC80FQ28083039-761900EC-8A4D-45EF-845F-0588DAFF82E3Q28086892-9D133802-B2AF-4FAE-A937-51E22203E38FQ28481242-FC10B8E0-26F3-4917-B69E-0312310BDD0BQ28533808-D7BF37CC-6B3A-42B8-AA79-E3FED03740D7Q28546885-0FAEA949-2666-451D-B67F-BAE3D101A5F6Q28550675-571B0D42-276D-4196-80F0-F6B30178437BQ28830946-AAB8CC1A-D8CA-4293-82FE-E69AE8DE22DEQ30365939-1D9C1556-B296-441A-B768-E983FC81F21CQ30394286-D2B5410F-FCF2-42A0-8657-215B6A1FF98FQ30531048-170D0B3D-2C92-43F3-BE6A-EEEB587362CBQ33603384-3584F2EB-4818-41A2-95F1-8ADA803A1248Q33628048-CC041206-B934-48BA-AB4E-37184E40310DQ33807853-E55BE7A5-86A6-4D77-A2CB-443F87FAF9EEQ33866808-E04AF60B-065C-4A48-85F2-F127D8BD50FCQ34028497-AE80A100-E745-4503-8F24-1ACF0897A57EQ34167980-006930E1-8E3B-4A08-8371-193A38FCCF5DQ34215215-48F46A93-D1BE-48FE-81FA-61893807DD81Q34256889-8F2C1DCC-2892-4D60-830F-28188E069828Q34362412-845DFB21-4860-4FEF-A01B-22729A32F043Q34603106-50903CCA-B9D3-4F27-AF7F-DF759666FF05Q35061438-63886C63-69D0-4F3B-83D7-77863C9AEA25Q35180081-3273A16B-E2A2-4F65-B20A-BED29323140EQ35226164-AF440AB0-A703-492B-B505-38EF2B1C597EQ35564256-3303B28B-80EF-441B-B02E-00E641DB7132Q35760279-A4F36A5F-CFD8-4EE7-A793-63E369AED8A8Q36166654-8901BA9B-8603-4EE4-BEE5-72F6F31B21CAQ36279695-45863E28-630D-460A-B9DA-CA3790359C87Q36406906-3D620363-D025-4E1B-80FC-5F949F4BCF1EQ36471528-8B9A8CF1-73BA-4AD5-BD7C-DEDFF756647FQ36477770-239BBC13-9218-4B83-8F60-39FE77A2A6B8Q36539234-E6CA55AA-3914-434C-AA15-8D084A821EA8Q36907068-AE8ADB3F-7F85-4ED7-8D1F-F9F451E397A5Q37078997-B73EA463-E735-45C2-8C3C-148AA9A37CE1Q37355794-89C17E40-2FEB-4738-BBD3-E0037BFC385DQ37686556-385D4609-D3EE-4585-93D0-14A218D6DD44Q37894864-579FAF4F-1E7D-4CC1-94C4-A19544DFF022
P2860
Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@ast
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@en
type
label
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@ast
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@en
prefLabel
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@ast
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@en
P2093
P2860
P1476
Evidence of GLP-1-mediated neu ...... peripheral sensory neuropathy.
@en
P2093
Ananda Weerasuriya
Harold W Holloway
Julie A Mattison
Kara Duffy
Nigel H Greig
Peter R Mouton
TracyAnn Perry
P2860
P304
P356
10.1016/J.EXPNEUROL.2006.09.028
P407
P577
2006-11-22T00:00:00Z